Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
LY4101174 for Solid Tumors
Recruiting1 awardPhase 1
New York, New York
"This trial is testing a new drug called LY4101174 to see if it is safe and effective for people with advanced solid tumors. The trial has two parts and will take about 4 years to
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service